Clinical Trials in Maryland

Showing 8201-8220 of 17,687 trials

Behavioral Activation Intervention, Reward Processing, and Youth Smoking Cessation

NCT01351766

The primary purpose of this study is to develop a specialized behavioral activation treatment for smoking in youths ages 18-21 with elevated depressive symptoms. In the first phase we utilize focus groups and pilot testing with 15 youths to develop the behavioral activation smoking treatment for youth. In Phase II, we will conduct an open-label trial of the new treatment that will include 8 weeks of transdermal nicotine patch, which will begin at the time of quitting smoking. Participants will be followed over 26 weeks post-quit date. A subset of participants will also undergo an fMRI session to examine reward sensitivity.

Smoking

University of Maryland, College Park39 participantsStarted Apr 2010

College Park, Maryland, United States

COMPLETED12 miles

Myelofibrosis and Essential Thrombocythemia Observational Study (MOST)

NCT02953704

The purpose of this prospective, longitudinal, noninterventional study is to describe clinical characteristics, evolution of disease burden, and treatment patterns in patients with select subcategories of essential thrombocythemia (ET) or myelofibrosis (MF).

MPN (Myeloproliferative Neoplasms)

Incyte Corporation1,469 participantsStarted Dec 2016

Huntsville, Alabama, United States • Tempe, Arizona, United States • Tucson, Arizona, United States +113 more locations

Behavioral Activation Intervention, Reward Processing, and Youth Smoking Cessation

Myelofibrosis and Essential Thrombocythemia Observational Study (MOST)

Find Trials by Condition in Maryland

Study to Evaluate the Efficacy and Safety of Perampanel as Monotherapy or First Adjunctive Therapy in Subjects With Partial Onset Seizures With or Without Secondarily Generalized Seizures or With Primary Generalized Tonic-Clonic Seizures

Safety and Efficacy of NBI-98854 in Pediatric Subjects With Tourette Syndrome

Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients With ALS

Subtotal Resection of Large Acoustic Neuromas With Possible Stereotactic Radiation Therapy

Struvite Stones Antibiotic Study

Multicenter Selective Lymphadenectomy Trial II (MSLT-II)

Extension Study to Evaluate the Long-Term Safety and Tolerability of Oral Atogepant for the Prevention of Migraine in Participants With Episodic Migraine

Assessment of Tecfidera® in Radiologically Isolated Syndrome (RIS)

Study to Evaluate Exemestane With and Without Entinostat (SNDX-275) in Treatment of Postmenopausal Women With Advanced Breast Cancer

A Study to Compare Efficacy and Safety of Trifarotene Cream When Used With an Oral Antibiotic for the Treatment of Severe Acne Vulgaris (AV)

EndoPredict® Extended Endocrine Trial (EXET)

Dehydrated Human Umbilical Cord Allograft in the Management of Diabetic Foot Ulcers

Phase 3 Study of Pexidartinib for Pigmented Villonodular Synovitis (PVNS) or Giant Cell Tumor of the Tendon Sheath (GCT-TS)

Bi 671800 in Asthmatic Patients on Inhaled Corticosteroids

RRx-001 in Combination With Irinotecan in Metastatic or Advanced Cancer (PAYLOAD)

Renew NCP-5 for the Treatment of Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild Dementia of the Alzheimer's Type

CHoice of OptImal transCatheter trEatment for Mitral Insufficiency Registry

A Study to Investigate the Safety and Efficacy of Emapalumab, an Anti-IFN-gamma mAb in Patients With Systemic Juvenile Idiopathic Arthritis (sJIA) or Adult-onset Still's Disease (AOSD) Developing Macrophage Activation Syndrome/Secondary HLH (MAS/sHLH)